Navigation Links
Evaluation of standard liver volume formula for Chinese adults
Date:9/16/2009

Living donor liver transplantation (LDLT) has been used to alleviate the shortage of available liver donors. Accurate estimation of the standard liver volume (SLV) of the living donor and recipient is crucial. Scholars of different countries established several SLV formulae from clinical data, but which formula was the most accurate for Chinese adults has remained unclear.

A research article to be published on August 28, 2009 in the World Journal of Gastroenterology, addresses this question. The research team led by Prof. Lu-Nan Yan from West China Hospital, Sichuan University evaluated reported SLV formulae using data of 76 cases of LDLT from January 2008 to April 2009.

The results demonstrated that the Chengdu formula was reliable by its applicability in LDLT. Statistical analysis showed that the Fan formula tended to underestimate SLV. The Heinemann, Urata, Vauthey, and Lee formulae overestimated SLV.

With national multicenter data in the future, the Chengdu formula for SLV can be improved. That may be applied to the evaluation of Chinese donors and recipients for LDLT.


'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Sinovacs H1N1 Vaccine Passes Experts Evaluation Organized by SFDA
2. Drug Companies Often Unprepared For REMS Evaluation, Expert Warns
3. WellPoints Contribution To Drug Formulary Evaluation Standards Highlighted in ISPOR Publication
4. Patients with moderate to severe periodontitis need evaluation for heart disease risk
5. Evaluation shows $167 million investment improves community mental health system, but many still in need
6. More stringent evaluation on the use of generic medications in thoracic transplantation
7. QLT announces positive results from the evaluation of Visudyne(R) combination therapy
8. Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier
9. Pennsylvania DEP Releases Evaluation of Air Quality Program
10. Bradmer provides clinical trial update and announces evaluation of strategic alternatives
11. Charleston Conducts Evaluation of an Opioid Symptoms Questionnaire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... , ... Harbour , a DAO (decentralized autonomous organization) that harnesses the ... their technical specifications . , 2017 has seen an explosion of token launches ... which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, ...
(Date:6/27/2017)... , ... June 27, 2017 , ... A January 18th ... projected to reach a staggering $6.81 billion by the year 2024 according to a ... a faster rate than those made from titanium. Los Angeles area clinic Beverly Hills ...
(Date:6/27/2017)... ... June 27, 2017 , ... Drs. Gregory Toback and ... in Mystic, CT. Covering the process and maintenance strategies of gum grafting and ... periodontal procedures. Drs. Toback and Urbanski practice as experienced periodontists in ...
(Date:6/27/2017)... Los Angeles, CA (PRWEB) , ... June 27, 2017 , ... ... on what crooked bites can indicate about early life experiences. What happens to a ... study reveals that stresses after birth can also take a toll on a baby’s ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced Orthopaedics ... of Richard Robinson as chief operating officer (COO). In this role, Robinson brings ... track record of simplifying business processes and developing growth strategies to increase market ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology: